Eddy Shih-Hsin Yang (Eddy S Yang, Eddy Yang)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 32

Top Topics

Metastatic Renal Cell Carcinoma

Epidermal Growth Factor Receptor

Dna Damage Response

Top Venues

Breast cancer research and treatment

JCO precision oncology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Timothy L Cannon, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Vi K Chiu, Jimmy Hwang, Namrata Vijayvergia, Olatunji B Alese, Elie G Dib, Herbert L Duvivier, Kelsey A Klute, Vaibhav Sahai, Eugene R Ahn, Pablo Bedano, Deepti Behl, Sarah Sinclair, Ramya Thota, Walter J Urba, Eddy Shih-Hsin Yang, Gina N Grantham, Dominique C Hinshaw, Abigail Gregory, Susan Halabi, Richard L Schilsky
Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With ERBB2/3 Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Ameer Mansur, Patrick N Song, Yun Lu, Andrew C Burns, Luke Sligh, Eddy Shih-Hsin Yang, Anna G Sorace
Combination Therapy with Trastuzumab and Niraparib: Quantifying Early Proliferative Alterations in HER2+ Breast Cancer Models. Biomedicines 11 (8) (2023)
Christos Vaklavas, Erica M Stringer-Reasor, Ahmed M Elkhanany, Kevin J Ryan, Yufeng Li, Charles P Theuer, Edward P Acosta, Shi Wei, Eddy Shih-Hsin Yang, William E Grizzle, Andres Forero-Torres
A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer. Breast cancer research and treatment 198 (2) (2023)
Nadine J Barrett, Leigh M Boehmer, Janelle Schrag, Al Bowen Benson, Sybil Green, Leila Hamroun-Yazid, Alexandra Howson, Khalid Matin, Randall A Oyer, Lori J Pierce, Sanford E Jeames, Karen M Winkfield, Eddy Shih-Hsin Yang, Victoria Zwicker, Suanna Steeby Bruinooge, Patricia A Hurley, Jen Hanley Williams, Carmen E Guerra
An Assessment of the Feasibility and Utility of an ACCC-ASCO Implicit Bias Training Program to Enhance Racial and Ethnic Diversity in Cancer Clinical Trials. JCO oncology practice (2023)
Eddy Shih-Hsin Yang, Susan Halabi, Michael Rothe, Elizabeth Garrett-Mayer, Pam K Mangat, Evan Pisick, Elie G Dib, Earle F Burgess, Michael Zakem, Nitin Rohatgi, Mehmet A Bilen, Raegan O'Lone, Gina N Grantham, Richard L Schilsky
Olaparib in Patients With Metastatic Prostate Cancer With BRCA1 / 2 Mutation: Results From the TAPUR Study. JCO precision oncology 7 (2023)
Eddy Shih-Hsin Yang, Susan Halabi, Michael Rothe, Elizabeth Garrett-Mayer, Pam K Mangat, Evan Pisick, Elie G Dib, Earle F Burgess, Michael Zakem, Nitin Rohatgi, Mehmet A Bilen, Raegan O'Lone, Gina N Grantham, Richard L Schilsky
Olaparib in Patients With Metastatic Prostate Cancer With BRCA1 / 2 Mutation: Results From the TAPUR Study. JCO precision oncology 7 (2023)
Benjamin J Bulen, Nickolay A Khazanov, Daniel H Hovelson, Laura E Lamb, Marc Matrana, Mark E Burkard, Eddy Shih-Hsin Yang, William Jeffery Edenfield, Elizabeth C Dees, Adedayo A Onitilo, Gary L Buchschacher, Alan M Miller, Benjamin M Parsons, Timothy R Wassenaar, Jennifer M Suga, Robert D Siegel, William Irvin, Suresh G Nair, Jennifer N Slim, Jamal Misleh, Jamil Khatri, Gregory A Masters, Sachdev Thomas, Malek M Safa, Daniel M Anderson, Jonathan Mowers, Anna C Dusenbery, Stephanie Drewery, Komal Plouffe, Travis Reeder, Hana Vakil, Lynnae Patrias, Amanda Falzetta, Ryan Hamilton, Kat Kwiatkowski, D Bryan Johnson, Daniel R Rhodes, Scott A Tomlins
Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit. Cancer research communications 3 (7) (2023)
Christos Vaklavas, Erica M Stringer-Reasor, Ahmed M Elkhanany, Kevin J Ryan, Yufeng Li, Charles P Theuer, Edward P Acosta, Shi Wei, Eddy Shih-Hsin Yang, William E Grizzle, Andres Forero-Torres
A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer. Breast cancer research and treatment 198 (2) (2023)
Christos Vaklavas, Erica M Stringer-Reasor, Ahmed M Elkhanany, Kevin J Ryan, Yufeng Li, Charles P Theuer, Edward P Acosta, Shi Wei, Eddy Shih-Hsin Yang, William E Grizzle, Andres Forero-Torres
A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer. Breast cancer research and treatment 198 (2) (2023)
Christos Vaklavas, Erica M Stringer-Reasor, Ahmed M Elkhanany, Kevin J Ryan, Yufeng Li, Charles P Theuer, Edward P Acosta, Shi Wei, Eddy Shih-Hsin Yang, William E Grizzle, Andres Forero-Torres
A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer. Breast cancer research and treatment 198 (2) (2023)
Eddy Shih-Hsin Yang, Susan Halabi, Michael Rothe, Elizabeth Garrett-Mayer, Pam K Mangat, Evan Pisick, Elie G Dib, Earle F Burgess, Michael Zakem, Nitin Rohatgi, Mehmet A Bilen, Raegan O'Lone, Gina N Grantham, Richard L Schilsky
Olaparib in Patients With Metastatic Prostate Cancer With BRCA1 / 2 Mutation: Results From the TAPUR Study. JCO precision oncology 7 (2023)
Christos Vaklavas, Erica M Stringer-Reasor, Ahmed M Elkhanany, Kevin J Ryan, Yufeng Li, Charles P Theuer, Edward P Acosta, Shi Wei, Eddy Shih-Hsin Yang, William E Grizzle, Andres Forero-Torres
A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer. Breast cancer research and treatment 198 (2) (2023)
Christos Vaklavas, Erica M Stringer-Reasor, Ahmed M Elkhanany, Kevin J Ryan, Yufeng Li, Charles P Theuer, Edward P Acosta, Shi Wei, Eddy Shih-Hsin Yang, William E Grizzle, Andres Forero-Torres
A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer. Breast cancer research and treatment (2023)
Zachary Quinn, Benjamin E Leiby, Guru P Sonpavde, Atish D Choudhury, Christopher J Sweeney, David J Einstein, Russell Zelig Szmulewitz, A Oliver Sartor, Beatrice Knudsen, Eddy Shih-Hsin Yang, William Kevin Kelly
Phase I Study of Niraparib in Combination with Radium-223 for the Treatment of Metastatic Castrate Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Patrick N Song, Ameer Mansur, Yun Lu, Deborah Della Manna, Andrew C Burns, Sharon Samuel, Katherine Heinzman, Suzanne E Lapi, Eddy Shih-Hsin Yang, Anna G Sorace
Modulation of the Tumor Microenvironment with Trastuzumab Enables Radiosensitization in HER2+ Breast Cancer. Cancers 14 (4) (2022)
Philippe L Bedard, Shuli Li, Kari B Wisinski, Eddy Shih-Hsin Yang, Sewanti A Limaye, Edith P Mitchell, James A Zwiebel, Jeffrey A Moscow, Robert C Gray, Victoria Wang, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Phase II Study of Afatinib in Patients With Tumors With Human Epidermal Growth Factor Receptor 2-Activating Mutations: Results From the National Cancer Institute-Molecular Analysis for Therapy Choice ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-B. JCO precision oncology 6 (2022)
Hongxing Shen, Fengyuan Huang, Xiangmin Zhang, Oluwagbemiga A Ojo, Yuebin Li, Hoa Quang Trummell, Joshua C Anderson, John Fiveash, Markus Bredel, Eddy Shih-Hsin Yang, Christopher D Willey, Zechen Chong, James A Bonner, Lewis Zhichang Shi
Selective suppression of melanoma lacking IFN-γ pathway by JAK inhibition depends on T cells and host TNF signaling. Nature communications 13 (1) (2022)
Randall A Oyer, Patricia A Hurley, Leigh M Boehmer, Suanna Steeby Bruinooge, Kathryn Levit, Nadine J Barrett, Al Bowen Benson, Lea Ann Bernick, Leslie Byatt, Marjory Charlot, Jennie Crews, Kyle DeLeon, Lola A Fashoyin-Aje, Elizabeth Garrett-Mayer, Julie R Gralow, Sybil Green, Carmen E Guerra, Leila Hamroun, Claudia M Hardy, Bridgette Hempstead, Sanford E Jeames, Mel Mann, Khalid Matin, Worta McCaskill-Stevens, Janette K Merrill, Grzegorz S Nowakowski, Manali I Patel, Alice R Pressman, Amelie G Ramirez, Juanita Segura, Barbara Segarra-Vasquez, Jen Hanley Williams, James E Williams, Karen M Winkfield, Eddy Shih-Hsin Yang, Victoria Zwicker, Lori J Pierce
Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (19) (2022)
Aubrey L Miller, Patrick L Garcia, Samuel C Fehling, Tracy L Gamblin, Rebecca B Vance, Leona N Council, Dongquan Chen, Eddy Shih-Hsin Yang, Robert C A M van Waardenburg, Karina J Yoon
The BET Inhibitor JQ1 Augments the Antitumor Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer. Cancers 13 (14) (2021)
Yingnan Si, Ya Zhang, Hanh Giai Ngo, Jia-Shiung Guan, Kai Chen, Qing Wang, Ajeet Pal Singh, Yuanxin Xu, Lufang Zhou, Eddy Shih-Hsin Yang, Xiaoguang Margaret Liu
Targeted Liposomal Chemotherapies to Treat Triple-Negative Breast Cancer. Cancers 13 (15) (2021)
Erica M Stringer-Reasor, Jori E May, Eva Olariu, Valerie Caterinicchia, Yufeng Li, Dongquan Chen, Deborah L Della Manna, Gabrielle B Rocque, Christos Vaklavas, Carla I Falkson, Lisle M Nabell, Edward P Acosta, Andres Forero-Torres, Eddy Shih-Hsin Yang
An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer. Breast cancer research : BCR 23 (1) (2021)
Yingnan Si, Ya Zhang, Jia-Shiung Guan, Hanh Giai Ngo, Angela Totoro, Ajeet Pal Singh, Kai Chen, Yuanxin Xu, Eddy Shih-Hsin Yang, Lufang Zhou, Runhua Liu, Xiaoguang Margaret Liu
Anti-CD47 Monoclonal Antibody-Drug Conjugate: A Targeted Therapy to Treat Triple-Negative Breast Cancers. Vaccines 9 (8) (2021)
Eddy Shih-Hsin Yang, Amin H Nassar, Elio Adib, Opeyemi A Jagede, Sarah Abou Alaiwi, Deborah L Della Manna, David A Braun, Mahsa Zarei, Heng Du, Sumanta K Pal, Gurudatta Naik, Guru P Sonpavde
Gene Expression Signature Correlates with Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with Everolimus Alone or with a Vascular Disrupting Agent. Molecular cancer therapeutics 20 (8) (2021)
Kirsten M Reeves, Patrick N Song, Allyson Angermeier, Deborah Della Manna, Yufeng Li, Jianbo Wang, Eddy Shih-Hsin Yang, Anna G Sorace, Benjamin M Larimer
18F-FMISO PET Imaging Identifies Hypoxia and Immunosuppressive Tumor Microenvironments and Guides Targeted Evofosfamide Therapy in Tumors Refractory to PD-1 and CTLA-4 Inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Vipin Rawat, Parmanand Malvi, Deborah Della Manna, Eddy Shih-Hsin Yang, Suresh Bugide, Xuchen Zhang, Romi Gupta, Narendra Wajapeyee
PSPH promotes melanoma growth and metastasis by metabolic deregulation-mediated transcriptional activation of NR4A1. Oncogene 40 (13) (2021)
Zhuo Zhang, Lin Luo, Chuan Xing, Yu Chen, Peng Xu, Mao Li, Ling Zeng, Chao Li, Sadashib Ghosh, Deborah Della Manna, Tim Townes, William J Britt, Narendra Wajapeyee, Barry P Sleckman, Zechen Chong, Jianmei Wu Leavenworth, Eddy Shih-Hsin Yang
RNF2 ablation reprograms the tumor-immune microenvironment and stimulates durable NK and CD4 + T-cell-dependent antitumor immunity. Nature cancer 2 (10) (2021)
Suresh Bugide, Keshab Raj Parajuli, Suresh Chava, Rudradip Pattanayak, Deborah L Della Manna, Deepmala Shrestha, Eddy Shih-Hsin Yang, Guoping Cai, Douglas B Johnson, Romi Gupta
Loss of HAT1 expression confers BRAFV600E inhibitor resistance to melanoma cells by activating MAPK signaling via IGF1R. Oncogenesis 9 (5) (2020)
Soniya Bastola, Marat S Pavlyukov, Daisuke Yamashita, Sadashib Ghosh, Heejin Cho, Noritaka Kagaya, Zhuo Zhang, Mutsuko Minata, Yeri Lee, Hirokazu Sadahiro, Shinobu Yamaguchi, Svetlana Komarova, Eddy Shih-Hsin Yang, James Markert, Louis Burt Nabors, Krishna Bhat, James Lee, Qin Chen, David K Crossman, Teppei Kawahara, Do-Hyun Nam, Ichiro Nakano
Glioma-initiating cells at tumor edge gain signals from tumor core cells to promote their malignancy. Nature communications 11 (1) (2020)
Ling Zeng, Anatoly Nikolaev, Chuan Xing, Deborah L Della Manna, Eddy Shih-Hsin Yang
CHK1/2 Inhibitor Prexasertib Suppresses NOTCH Signaling and Enhances Cytotoxicity of Cisplatin and Radiation in Head and Neck Squamous Cell Carcinoma. Molecular cancer therapeutics 19 (6) (2020)
Anatoly Nikolaev, John B Fiveash, Eddy Shih-Hsin Yang
Combined Targeting of Mutant p53 and Jumonji Family Histone Demethylase Augments Therapeutic Efficacy of Radiation in H3K27M DIPG. International journal of molecular sciences 21 (2) (2020)
Nadine M Tung, Mark E Robson, Steffen Ventz, Cesar A Santa-Maria, Rita Nanda, P Kelly Marcom, Payal Deepak Shah, Tarah J Ballinger, Eddy Shih-Hsin Yang, Shaveta Vinayak, Michelle E Melisko, Adam M Brufsky, Michelle DeMeo, Colby Jenkins, Susan M Domchek, Alan D' Andrea, Nancy U Lin, Melissa E Hughes, Lisa Anne Carey, Nikhil Wagle, Gerburg M Wulf, Ian E Krop, Antonio C Wolff, Eric P Winer, Judy E Garber
TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (36) (2020)
Humaira Jamshed, Robbie A Beyl, Deborah L Della Manna, Eddy Shih-Hsin Yang, Eric Ravussin, Courtney M Peterson
Early Time-Restricted Feeding Improves 24-Hour Glucose Levels and Affects Markers of the Circadian Clock, Aging, and Autophagy in Humans. Nutrients 11 (6) (2019)